These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 24343819)
1. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326 [TBL] [Abstract][Full Text] [Related]
3. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393 [TBL] [Abstract][Full Text] [Related]
4. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Huth TK; Staines D; Marshall-Gradisnik S J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723 [TBL] [Abstract][Full Text] [Related]
5. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. Ramos S; Brenu E; Broadley S; Kwiatek R; Ng J; Nguyen T; Freeman S; Staines D; Marshall-Gradisnik S Asian Pac J Allergy Immunol; 2016 Dec; 34(4):300-305. PubMed ID: 27001659 [TBL] [Abstract][Full Text] [Related]
6. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL; Palencia T; Fernández G; García M Front Immunol; 2018; 9():1028. PubMed ID: 29867995 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM J Transl Med; 2012 May; 10():88. PubMed ID: 22571715 [TBL] [Abstract][Full Text] [Related]
8. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation. Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers. Maes M; Bosmans E; Kubera M Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044 [TBL] [Abstract][Full Text] [Related]
12. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery. Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J Front Immunol; 2020; 11():582330. PubMed ID: 33329554 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
14. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818 [TBL] [Abstract][Full Text] [Related]
15. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome. Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093 [TBL] [Abstract][Full Text] [Related]
17. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients. Nguyen T; Staines D; Nilius B; Smith P; Marshall-Gradisnik S Biol Res; 2016 May; 49(1):27. PubMed ID: 27245705 [TBL] [Abstract][Full Text] [Related]